市场调查报告书
商品编码
1273497
创伤性脑损伤评估和管理设备市场—增长、趋势和预测 (2023-2028)Traumatic Brain Injury Assessment and Management Devices Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内,外伤性脑损伤评估和管理设备市场预计将以 5.4% 的复合年增长率註册。
COVID-19 大流行对世界各地的医疗保健系统产生了深远影响。 因此,外科疾病的转诊模式、管理和康復发生了重大变化。 例如,2021 年 12 月发表在《世界神经外科》(World Neurosurgery) 上的一篇关于创伤性脑损伤 (TBI) 的论文发现,英国的手术管理已大大减少,而且在大流行期间,TBI 患者没有在神经外科设施之外接受神经外科治疗。更有可能在医疗支持下在当地进行管理。
政府在 COVID-19 期间实施的限制扰乱了 TBI 患者的管理。 此外,由于 COVID-19 的限制,创伤性脑损伤病例已大幅减少。 例如,根据上述同一项研究,在英国,与去年同期相比,大流行期间与道路交通事故 (RTA) 相关的死亡人数下降了 22%。 因此,大流行期间 TBI 发病率的下降阻碍了所研究市场的增长。 然而,自封锁限制解除以来,该行业已经恢復良好。 由于手术恢復后对手术、治疗和就诊的需求增加,预计在预测期内对 TBI 评估和管理设备的需求将会增加。
推动市场增长的某些因素包括外伤性脑损伤发生率的增加和主要市场参与者的举措。 2022 年 4 月,BMJ 期刊发表文章称,印度占全球新发创伤性脑损伤病例的 21%,占全球所有创伤性死亡病例的近四分之一。 此外,根据 2021 年 3 月发表在《临床医学杂誌》上的一项研究,TBI 是英国一个主要且发展中的健康问题。 TBI 每年在英国造成约 900,000 次急诊 (ED) 就诊和超过 200,000 次住院,严重头部受伤的发生率在 10% 至 20% 之间。 因此,预计英国 TBI 的沉重负担将增加对 TBI 评估和管理设备的需求,从而推动市场的增长。
此外,併购、产品批准和发布等主要市场参与者的举措也是市场增长的因素。 例如,2021 年 2 月,美国 FDA 批准了一种新的小工具,旨在让 13 岁及以上的运动员在体育活动中戴在脖子上,以保护大脑免受重复性脑震盪副头部打击的影响。批准商业化。 Q项圈是一种非侵入性的C型项圈,通过对颈部施加压力,增加血容量,减少颅脑损伤后大脑在颅内空间的迁移。 这个小工具可以使某些与脑损伤相关的大脑异常不太可能发生。
然而,先进设备的高成本预计会阻碍市场增长。
医院是诊断和治疗疾病(包括创伤性脑损伤)的初级保健机构。 很大一部分人口依赖长期护理机构来诊断、管理和治疗各种脑损伤。 此外,交通事故和运动导致的脑损伤病例不断增加,到医院接受手术和康復治疗的患者数量不断增加,对住院治疗的需求很高。
此外,越来越多的患者护理医院预计将推动该细分市场的增长。 例如,2021 年 10 月,Penn Medicine 在美国开设了一家新医院 Pavillion。 医院提供心臟病学和心臟外科、内科和外科肿瘤学、神经病学和神经外科以及移植手术的住院治疗。 同样在 2020 年 9 月,印度总理纳伦德拉莫迪批准在比哈尔邦达尔班加建立新的全印度医学科学研究所 (AIIMS),为创伤性损伤和儿童神经病学提供各种培训项目。我们提供服务。
由于轻度脑损伤发病率上升和市场参与者的举措等因素,预计该市场在预测期内将显着增长。 根据 2022 年 1 月发表的 StatPearls 文章,美国每年约有 170 万人受到创伤性脑损伤,其中 15 至 19 岁的青少年和 65 岁及以上的成年人患 TBI 最多。据说很容易。 此外,根据同一消息来源,美国每年每 100,000 人中有 500 人遭受创伤性脑损伤。 需要改善护理和持续监测患者,以减轻越来越多的创伤性脑损伤的长期影响,这将刺激市场扩张。
此外,根据美国交通部 2021 年国家公路交通安全管理局的数据,2021 年上半年美国估计有 20,160 人死于道路交通事故,比上一年增加 18.4%。 因此,交通事故数量的增加预计会产生需要持续护理的创伤性脑损伤患者,这有望成为市场增长的推动力。
此外,重要的市场进入者在日本的存在和产品批准的进展也是市场的重要增长因素。 例如,i-STAT Alinity 平台是一种即时手持式创伤性脑损伤 (TBI) 血液检测设备,于 2021 年 1 月获得美国 FDA 批准。 同样,2021 年 3 月,BrainScope 宣布发布其第三个革命性的 FDA 批准算法,用于 BrainScope 设备。 脑震盪指数是脑震盪损伤的第一个生理指标,可帮助医生在基线、受伤时刻和恢復期间客观地检查患者。
创伤性脑损伤评估和管理设备市场竞争激烈,由几家大型企业组成。 NanoDx, Inc.、BrainScope、Compumedics、Elekta AB、Integra Lifesciences、Natus Medical Incorporated、Neural Analytics, Inc. 和 Nihon Kohden 等公司占有相当大的市场份额。
The traumatic brain injury assessment and management devices market is expected to register a CAGR of 5.4% during the forecast period.
The COVID-19 pandemic has had widespread consequences for healthcare systems around the world. It resulted in extensive changes to the referral patterns, management, and rehabilitation of surgical conditions. For instance, according to an article published in World Neurosurgery in December 2021 on traumatic brain injury (TBI), surgical management was significantly reduced in the United Kingdom, and TBI patients were more likely to be managed locally with neurosurgical assistance outside of the neurosurgical facility during the pandemic.
Restrictions put in place by the government during COVID-19 disrupted the management of TBI patients. Additionally, traumatic brain injury instances have dramatically decreased as a result of COVID-19 limits. For instance, as per the same study mentioned above, road traffic accident (RTA)-related fatalities decreased by 22% in the UK between the pandemic period and the same period the previous year. As a result, the decrease in TBI incidence during the pandemic hampered the growth of the studied market. However, since the lockdown restrictions were lifted, the industry has been recovering well. The demand for surgical operations, treatments, and hospital visits rises as procedures are resumed, which is expected to increase the demand for TBI assessment and management devices over the forecast period.
Certain factors driving the market growth include the increasing incidence of traumatic brain injuries and initiatives by key market players. In April 2022, the BMJ Journals published an article stating that India is responsible for 21% of all new traumatic brain injury cases and nearly a quarter of all traumatic death cases worldwide. Additionally, according to a study published in the Clinical Medicine Journal in March 2021, TBI is a major and developing health issue in the United Kingdom. TBI is responsible for around 900,000 emergency department (ED) visits and over 200,000 hospital admissions in England each year and the rate of severe head imhury is between 10% and 20%. Thus, significant burden of TBI in England is expected to increase the demand for TBI assessment and management devices, which is likely to boost the market growth.
Furthermore, initiatives by key market players such as mergers and acquisitions, product approval as well as launches, are other factors contributing to the market growth. For instance, in February 2021, the US FDA approved the commercialization of a novel gadget designed to be worn around the neck of athletes aged 13 years and above during sporting activities to help protect the brain from the consequences of repetitive sub-concussive head blows. The Q-Collar is a non-invasive C-shaped collar that applies compressive force to the neck and increases blood volume to help reduce brain movement within the cranial space after a head trauma. The gadget may lessen the occurrence of specific brain abnormalities linked with brain injury.
However, the high cost of advanced devices is expected to hinder market growth.
Hospitals are the primary care settings for diagnosing and treating medical conditions, including traumatic brain injury. A significant proportion of the population depends on long-term care facilities to diagnose, manage, and treat different brain injuries. Moreover, the increasing number of brain injury cases due to road accidents and sports-related brain injuries, leading to an increase in several patient visits for surgery and rehabilitation procedures in hospitals, indicates the high demand for treatment in hospitals.
Furthermore, the growing number of hospitals for patient care is expected to boost segment growth. For instance, in October 2021, Penn Medicine launched a new hospital, Pavillion, in the United States. The hospital provides inpatient care for cardiology and cardiac surgery, medical and surgical oncology, neurology and neurosurgery, and transplant surgery. Also, in September 2020, the Prime Minister of India, Shri Narendra Modi, approved the establishment of a new All India Institute of Medical Sciences (AIIMS) in Darbhanga, Bihar, which offers various services for traumatic injury and child neurology.
The market is expected to grow significantly during the forecast period owing to factors such as the rising incidence of mild brain traumatic injuries and initiatives by market players. According to a StatPearls article published in January 2022, traumatic brain injury affects around 1.7 million people in the United States each year, with adolescents aged 15 to 19 years and adults aged 65 years and older being the most likely to develop TBI. In addition, as per the same source, there are 500 traumatic brain injuries per 100,000 people in the United States each year. To lessen the long-term effects of the population's increasing rate of traumatic injuries, improved care, and ongoing patient monitoring are required, which will spur market expansion.
Additionally, according to National Highway Traffic Safety Administration data for 2021 from the United States Department of Transportation, there were an estimated 20,160 traffic fatalities in the first half of 2021 in the United States, up 18.4% from the prior year. Therefore, the rising number of traffic accidents is likely to result in patients suffering from traumatic brain injuries who need ongoing care, which is anticipated to drive market growth.
Furthermore, the presence of significant market participants in the nation and the rise in product approvals are important growth factors for the market. For instance, the i-STAT Alinity platform, an immediate handheld traumatic brain injury (TBI) blood test gadget, was approved by the US FDA in January 2021. Similarly, in March 2021, BrainScope announced the release of its third innovative FDA-cleared algorithm for use with the BrainScope device. The Concussion Index is the first physiological marker of concussive damage that helps doctors objectively examine patients at baseline, at the moment of injury, and during recovery.
The traumatic brain injury assessment and management devices market is competitive and consists of a few major players. Companies like NanoDx, Inc., BrainScope, Compumedics, Elekta AB, Integra Lifesciences, Natus Medical Incorporated, Neural Analytics, Inc., Nihon Kohden Corporation, among others, hold a substantial market share in the market.